|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
156
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
170
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, surgical treatment
|
|
1
|
157
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
174
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
176
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR
|
|
1
|
135
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum
|
|
1
|
144
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
145
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
142
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, surgically treatment
|
|
1
|
140
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR
|
|
1
|
139
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
133
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
141
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR, surgically treated
|
|
1
|
135
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
143
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon oncological treatment, no surgery
|
|
1
|
140
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon surgical treatment
|
|
1
|
157
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon, no surgery or oncological treatment
|
|
1
|
166
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon
|
|
1
|
145
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR
|
|
1
|
141
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, oncological treatment no surgery
|
|
1
|
154
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, surgical treatment
|
|
1
|
145
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
142
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no curative surgery
|
|
1
|
140
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, treated with curative intended surgery
|
|
1
|
146
|
September 18, 2023
|
|
Phenotype submission: Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
140
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, no curative intended surgery and oncological treatment
|
|
1
|
134
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, no curative intended surgery
|
|
1
|
133
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma cancer reciving surgical treatment
|
|
1
|
153
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
109
|
September 18, 2023
|
